Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Immunogenicity
100%
Human Volunteers
100%
Gp120
100%
Transmission-blocking Vaccine
100%
Humoral Immunity
50%
First Use
50%
High Affinity
50%
Peptide Conjugates
50%
Immunogenic
50%
Vaccination
50%
Pregnant Women
50%
Vaccine Trial
50%
Domain Peptide
50%
Diphtheria Toxoid
50%
Randomized Controlled Trial
50%
Cell Wall
50%
Tetanus Toxoid
50%
Healthy Volunteers
50%
HIV-infected Mothers
50%
Normal Human
50%
Fetus
50%
HIV-positive
50%
Peptide Vaccine
50%
Neutralizing Antibodies
50%
HIV Seropositive
50%
Broad-spectrum Antibody
50%
Immunology and Microbiology
Human Immunodeficiency Virus
100%
Acquired Immune Deficiency Syndrome
100%
Normal Human
50%
Immunogenicity
50%
Peptide Vaccine
25%
Diphtheria Toxoid
25%
Tetanus Vaccine
25%
Neutralizing Antibody
25%
Cell Wall
25%
Mycobacterium Bovis BCG
25%
Humoral Immunity
25%
Antibody Affinity
25%
Infection
25%
Protein Tertiary Structure
25%
Peptides
25%
Infectious Disease
25%
Pharmacology, Toxicology and Pharmaceutical Science
Acquired Immune Deficiency Syndrome
100%
HIV
100%
Normal Human
50%
Immunogenicity
50%
Peptide
50%
Infection
25%
Neutralizing Antibody
25%
Mycobacterium Bovis BCG
25%
Guanosine Phosphate
25%
Diphtheria Toxoid
25%
Vaccination
25%
Randomized Controlled Trial
25%
Tetanus Toxoid
25%
Peptide Vaccine
25%